|Positive WB detected in||NIH/3T3 cells, A431 cells, A375 cells|
|Positive IP detected in||mouse brain tissue|
|Positive IHC detected in||human malignant melanoma tissue, human thyroid cancer tissue, human testis tissue|
Note: suggested antigen retrieval with TE buffer pH 9.0; (*) Alternatively, antigen retrieval may be performed with citrate buffer pH 6.0
|Positive IF detected in||NIH/3T3 cells|
|Western Blot (WB)||WB : 1:500-1:1000|
|Immunoprecipitation (IP)||IP : 0.5-4.0 ug for IP and 1:200-1:1000 for WB|
|Immunohistochemistry (IHC)||IHC : 1:100-1:400|
|Immunofluorescence (IF)||IF : 1:50-1:500|
|Sample-dependent, check data in validation data gallery|
The immunogen of 20899-1-AP is BRAF Fusion Protein expressed in E. coli.
|Tested Reactivity||human, mouse|
|Host / Isotype||Rabbit / IgG|
|Immunogen||BRAF fusion protein Ag15014|
|Full Name||v-raf murine sarcoma viral oncogene homolog B1|
|Calculated molecular weight||766 aa, 84 kDa|
|GenBank accession number||BC101757|
|Gene ID (NCBI)||673|
|Purification Method||Antigen affinity purification|
|Storage Buffer||PBS with 0.02% sodium azide and 50% glycerol pH 7.3.|
|Storage Conditions||Store at -20°C. Stable for one year after shipment. Aliquoting is unnecessary for -20oC storage.|
B-Raf proto-oncogene serine/threonine kinase(BRAF), is a protein belonging to the raf/mil family of serine/threonine protein kinases. BRAF plays a role in regulating the MAP kinase/ERKs signaling pathway, which affects cell division, differentiation, and secretion. BRAF is associated with cardiofaciocutaneous syndrome, a disease characterized by heart defects, mental retardation and a distinctive facial appearance. BRAF is also associated with various cancers, including non-Hodgkin lymphoma, colorectal cancer, malignant melanoma, thyroid carcinoma, non-small cell lung carcinoma, and adenocarcinoma of lung. BRAF plays a role in the PD-1/PDL-1 pathway. In some cancers, BRAF is activated by rearrangements that fuse its kinase domain to 5' partner genes and then has different molecular weights (PMID: 23890088).
|Product Specific Protocols|
|WB protocol for BRAF antibody 20899-1-AP||Download protocol|
|IHC protocol for BRAF antibody 20899-1-AP||Download protocol|
|IF protocol for BRAF antibody 20899-1-AP||Download protocol|
|IP protocol for BRAF antibody 20899-1-AP||Download protocol|
|Click here to view our Standard Protocols|
Int J Cancer
VPS33B negatively modulated by nicotine functions as a tumor suppressor in colorectal cancer.
Turk J Biol
Comparison of anticarcinogenic properties of Viburnum opulus and its active compound p-coumaric acid on human colorectal carcinoma.
High expression of KITLG is a new hallmark activating the MAPK pathway in type A and AB thymoma.
Biochem Biophys Res Commun
Sex hormone-binding globulin regulates the activity of the ERK pathway in the placentas of patients with gestational diabetes mellitus.
Network pharmacology and molecular docking reveal the mechanism of Scopoletin against non-small cell lung cancer.